METTL3 (methyltransferase like 3), a component of the methyltransferase complex that catalyzes N6 methylation, is elevated in NSCLC and induces gefitinib resistance in NSCLC cells by enhancing autophagy-related gene expression [19]. This evidence concerns the gene METTL3 and non-small cell lung carcinoma.